Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Philippe Pouletty"'
Autor:
Pedro Giavina-Bianchi, MD, PhD, Eric Cua, MD, Karine Risso, MD, Véronique Mondain, MD, Anaïs Vissian, MSc, Cécile Joie, MSc, Philippe Pouletty, MD, Paul Gineste, PharmD, Hartmut J. Ehrlich, MD, PhD, Jorge Kalil, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 4, Pp 100140- (2023)
Background: ABX464 (obefazimod) is a small molecule that upregulates a single microRNA (miR-124) in immune cells and reduces the production of various inflammatory cytokines and chemokines. Objective: We assessed the efficacy and safety of the standa
Externí odkaz:
https://doaj.org/article/38018d98dfd24036bb65e23f3e7a3be0
Autor:
Julien Pothlichet, Annalisa Meola, Florence Bugault, Louise Jeammet, Anne G. Savitt, Berhane Ghebrehiwet, Lhousseine Touqui, Philippe Pouletty, Frédéric Fiore, Alain Sauvanet, Jacques Thèze
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The origin of the impaired CD4 T-cell response and immunodeficiency of HIV-infected patients is still only partially understood. We recently demonstrated that PLA2G1B phospholipase synergizes with the HIV gp41 envelope protein in HIV viremic plasma t
Externí odkaz:
https://doaj.org/article/b03bd2678ba64c0090485102c4cbf5f9
Autor:
Didier Scherrer, Noel Barrett, Luc Teyton, Tillman Pearce, Josianne Nitcheu, Philippe Pouletty, Julien Santo, Hartmut J. Ehrlich
Publikováno v:
Molecular Cancer Therapeutics. 21:1788-1797
Immune checkpoint blockers (ICB) provide a promising approach to antitumor immunotherapy through blockade of immunosuppressive pathways. The synthetic glycolipid, ABX196, is a potent stimulator of invariant natural killer T cells (iNKT), a small subs
Autor:
Hartmut J. Ehrlich, Julien Santo, Philippe Pouletty, Josianne Nitcheu, Tillman Pearce, Luc Teyton, Noel Barrett, Didier Scherrer
Supplementary Figure from Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756179482cb9b7fcd36a3727c5756534
https://doi.org/10.1158/1535-7163.22523904.v1
https://doi.org/10.1158/1535-7163.22523904.v1
Autor:
Hartmut J. Ehrlich, Julien Santo, Philippe Pouletty, Josianne Nitcheu, Tillman Pearce, Luc Teyton, Noel Barrett, Didier Scherrer
Supplementary Data from Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::609130139a65ecaaa5d286825fc3a9af
https://doi.org/10.1158/1535-7163.22523910.v1
https://doi.org/10.1158/1535-7163.22523910.v1
Autor:
Oriane Chaput, Derek Solt, Sivaprasad Sukavaneshvar, Nathalie Fenouil, Brian R. Burg, Philippe Pouletty, Stephan Haulon, Dominique Fabre
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 68(10)
Late and persistent type II endoleaks (EL2) following Endovascular Aneurysm Repair (EVAR) have been recognized as an independent and significant risk factor for aneurysm sac growth and secondary procedures. Solutions are available for treatment, with
Autor:
Nicolas Petrovic, Philippe Pouletty, Isabelle Guichot, Denis Blanc, Olivier Nicolas, Florian Reinaud, Gérard Saillant, Cécile Verdier
Oui, la crise a du génie : si elle a suspendu le temps social et économique, si elle a obligé les entreprises à ralentir voire à interrompre certaines de leurs activités, elle leur a aussi permis de redéfinir leurs priorités et de repousser l
Autor:
Christophe Misse, Guillaume Fusaï, David Braunstein, Annamaria Molon, François Bassompierre, Sophie Ravoire, Bruno François, Joëlle Micallef, Jacques Demotes, de Nathalie Donne, Jean-François Dhainaut, Bertrand Schwartz, Brigitte Pouletty-Lefebvre, Thomas Borel, Angela Baker, Stephane Huet, et avec la contribution sous forme d’audition, Eric Vicaut, Olivier Rascol, Vincent Diebolt, Philippe Pouletty
Publikováno v:
Therapies. 70:95-102
Resume Le lancement d’Horizon 2020, 8 e programme cadre de recherche et de developpement (PCRD) de l’Union Euro-peenne, dote de 79 milliards d’euros, est l’occasion de faire le bilan de la participation de la France aux precedents PCRD. Elle
Publikováno v:
médecine/sciences. 24:306-313
The abnormal cytokine release in the stromal microenvironment of pathologic tissues, contributes to the pathogenesis of viral infections such as AIDS, cancer and auto-immune diseases. Neovacs developed therapeutic vaccines, named Kinoids, which induc
Autor:
Jean-François, Dhainaut, Vincent, Diebolt, Brigitte, Pouletty-Lefèbvre, Angela, Baker, François, Bassompierre, Thomas, Borel, David, Braunstein, Jacques, Demotes, Bruno, François, Stéphane, Huet, Joëlle, Micallef, Christophe, Misse, Annamaria, Molon, Olivier, Rascol, Sophie, Ravoire, Bertrand, Schwartz, Nathalie, Donne, Guillaume, Fusaï, Philippe, Pouletty, Eric, Vicaut
Publikováno v:
Therapie. 70(1)
The initiation of Horizon 2020--the European Union's 8th Framework Programme for Research and Innovation, allotted a budget of 79 billion euros--provides an opportunity to review France's participation in previous Framework Programmes. Indeed, French